Want to see IN:CAMLINFINE full AI Analyst Report?
CAMLINFINE Stock Chart & Stats
₹144.30
-₹3.37(-2.50%)
At close: 4:00 PM EST
₹144.30
-₹3.37(-2.50%)
Day’s Range― - ―
52-Week Range₹96.30 - ₹311.95
Previous CloseN/A
Volume719.11K
Average Volume (3M)39.05K
Market Cap
₹26.16B
Enterprise Value₹32.58B
Total Cash (Recent Filing)₹1.63B
Total Debt (Recent Filing)₹6.72B
Price to Earnings (P/E)98.7
Beta0.69
Next Earnings
Aug 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.57
Shares Outstanding192,096,620
10 Day Avg. Volume26,894
30 Day Avg. Volume39,045
Financial Highlights & Ratios
PEG Ratio-0.56
Price to Book (P/B)1.76
Price to Sales (P/S)1.06
P/FCF Ratio-55.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)8.1
Revenue Forecast (FY)₹21.25B
Bulls Say, Bears Say
Bulls Say
Specialty Product Mix And B2B FocusCamlin Fine's focus on specialty antioxidants, aroma ingredients and customized blends creates higher technical barriers and customer qualification needs. That B2B, formulation-driven model supports sticky relationships, pricing power for differentiated products and a durable revenue base versus commoditized chemicals.
Improving Leverage On Balance SheetThe material reduction in leverage provides more financial flexibility and lowers refinancing risk, enabling the company to fund product development or absorb shocks. A stronger balance sheet is a lasting structural improvement that supports sustainable operations and strategic investments over the coming months.
Return To Positive Net IncomeResuming net profitability after multi-year losses indicates operational fixes or cost discipline that can persist. While margins remain thin, consistent profitability is a prerequisite for rebuilding cash flows, funding capex, and restoring investor confidence over a medium-term horizon.
Bears Say
Unstable Cash Generation And Negative FCFRepeated negative free cash flow limits the company's ability to self-fund growth, pay down debt, or return capital. Persistent working-capital pressure or reinvestment needs increase reliance on external financing, raising execution risk and constraining strategic options over the medium term.
Sharp FY2026 Revenue DeclineA near-45% annual revenue drop signals structural demand, customer or mix issues rather than transient weakness. Such large top-line volatility undermines forecasting, scale economics, and long-term contract credibility, making margin recovery and steady investment planning more difficult.
Sustained Margin CompressionSignificant, sustained margin erosion reduces the firm's buffer against cost shocks and weakens cashflow generation. Lower profitability limits reinvestment capability and makes the business more sensitive to raw material cycles and competitive pricing, pressuring durable earnings power.
Camlin Fine Sciences Limited News
CAMLINFINE FAQ
What was Camlin Fine Sciences Limited’s price range in the past 12 months?
Camlin Fine Sciences Limited lowest stock price was ₹96.30 and its highest was ₹311.95 in the past 12 months.
What is Camlin Fine Sciences Limited’s market cap?
Camlin Fine Sciences Limited’s market cap is ₹26.16B.
When is Camlin Fine Sciences Limited’s upcoming earnings report date?
Camlin Fine Sciences Limited’s upcoming earnings report date is Aug 07, 2026 which is in 35 days.
How were Camlin Fine Sciences Limited’s earnings last quarter?
Camlin Fine Sciences Limited released its earnings results on May 26, 2026. The company reported -₹1 earnings per share for the quarter, missing the consensus estimate of ₹0.1 by -₹1.1.
Is Camlin Fine Sciences Limited overvalued?
According to Wall Street analysts Camlin Fine Sciences Limited’s price is currently Overvalued.
Does Camlin Fine Sciences Limited pay dividends?
Camlin Fine Sciences Limited pays a Annually dividend of ₹0.45 which represents an annual dividend yield of N/A. See more information on Camlin Fine Sciences Limited dividends here
What is Camlin Fine Sciences Limited’s EPS estimate?
Camlin Fine Sciences Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Camlin Fine Sciences Limited have?
Camlin Fine Sciences Limited has 192,096,620 shares outstanding.
What happened to Camlin Fine Sciences Limited’s price movement after its last earnings report?
Camlin Fine Sciences Limited reported an EPS of -₹1 in its last earnings report, missing expectations of ₹0.1. Following the earnings report the stock price went down -1.1%.
Which hedge fund is a major shareholder of Camlin Fine Sciences Limited?
Currently, no hedge funds are holding shares in IN:CAMLINFINE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited, an India-based company headquartered in Mumbai and established in 1931 (originally as Camlin Fine Chemicals Limited until August 2011), is involved in the global research, development, production, and distribution of a diverse range of specialty chemicals, ingredients, and additive formulations. The company offers extensive shelf-life extension solutions under its Xtendra and NaSure brands. These include various antioxidants such as Tertiary Butyl Hydroquinone, Butylated Hydroxy Anisole, and Ascorbyl palmitate, alongside natural alternatives like mixed tocopherols, green tea extract, rosemary extract, and acerola extract. Additionally, its offerings comprise mold inhibitors, preservatives, acidifiers, antibacterial agents, toxin binders, pellet binders, and growth promoters. Its product line also features aroma ingredients, notably vanillin and ethyl vanillin, as well as nutraceuticals sourced through fermentation and plant extraction processes. Furthermore, Camlin Fine Sciences provides performance chemicals like hydroquinone and catechol, and a selection of downstream fine chemicals, including Guaiacol, Veratrole, TBC, MEHQ, and HQEE. These versatile products cater to numerous industries worldwide, encompassing food and beverage, pet food and animal nutrition, biodiesel, aquaculture, rendering, petrochemicals, agrochemicals, pharmaceuticals, polymers, dyes and pigments, biscuits and cookies, chocolate and confectionery, fragrance manufacturing, bakery, flavor, electroplating, and dietary supplements. The company actively engages in international exports of its goods.
Technical Analysis
Advanced Enzyme Technologies Ltd
―
Balaji Amines Limited
―
Neogen Chemicals Ltd.
―
Premier Explosives Limited
―
Rossari Biotech Ltd
―








